FDA Clears Non-Invasive Device for Migraine Treatment in Younger Patients
The FDA has granted marketing clearance for eNeura’s single-pulse transcranial magnetic stimulation device for use in patients ≥12 years for the acute and prophylactic treatment of migraine.